Analysis of Technological Developments in the Treatment of Alzheimer’s Disease through Patent Documents
Open Access
- 1 January 2015
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Intelligent Information Management
- Vol. 07 (05), 268-281
- https://doi.org/10.4236/iim.2015.75022
Abstract
Population aging and the consequent change in the profile of the age pyramid are already a reality the world over. One undeniable effect of this aging process is the significant increase in the number of people with Alzheimer’s disease (AD), which is the most common form of dementia, accounting for around 50% - 60% of all cases. AD tends to affect people in their 60 s, becoming progressively more commonplace in older age groups. It is an incurable disease, and patients can live for many years taking medication on a daily basis. This study shows that research into AD is on the rise around the world because the pharmaceutical industry and research institutions are seeking new types of drugs to treat and even cure Alzheimer’s patients. By analyzing patent documents, we map out the potential future treatments for this disease, indicating the leading countries and drugs companies that have invested most in a bid to accelerate progress towards new discoveries about the disease and the development of new drugs.Keywords
This publication has 55 references indexed in Scilit:
- Antioxidants for Alzheimer DiseaseArchives of Neurology, 2012
- Alzheimer Mechanisms and Therapeutic StrategiesCell, 2012
- Cholesterol Level and Statin Use in Alzheimer DiseaseArchives of Neurology, 2011
- The projected effect of risk factor reduction on Alzheimer's disease prevalenceThe Lancet Neurology, 2011
- Developing novel immunogens for a safe and effective Alzheimer's disease vaccinePublished by Elsevier BV ,2009
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- Ginkgo biloba for Prevention of DementiaA Randomized Controlled TrialJAMA, 2008
- Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse modelsThe Journal of Experimental Medicine, 2008
- Amyloid-β immunisation for Alzheimer's diseaseThe Lancet Neurology, 2008
- Stem cells for the treatment of neurological disordersNature, 2006